諾德股份(600110.SH)擬使用部分募集資金向青海電子增資6億元
格隆匯 12 月 17日丨諾德股份(600110.SH)公佈,公司擬使用非公開發行募集資金以現金方式對控股子公司青海電子增資6億元人民幣,再由青海電子對其控股子公司青海諾德新材料有限公司(“青海諾德”)增資6億元人民幣,增資價格分別以截至2020年9月30日青海電子、青海諾德全部股東權益評估結果為基礎確定。
此次增資是基於募投項目實施需要,符合募集資金使用計劃,有利於保障募投項目順利實施,促進募投項目早日發揮效益,符合公司發展戰略。募集資金的使用方式、用途等符合相關法律法規的規定,符合公司及全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.